Senior Vice President of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), Walkey Carl, sells 600 shares worth $6,114
According to Neoleukin Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 17 09:46 PM, company Senior Vice President, Walkey Carl disclosed selling 600 shares at a cost of $10.19. At the time of this transaction (Jun 16), this trade was worth $6,114 in total. As of Jun 16, Walkey Carl now owns 1,352,489 shares in total worth about $13,700,713.57.
For the last few recent trades made by Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Senior Vice President, Walkey Carl, we have the following information:
- SEC Form 4 filing: Jun 09: Sold 650 shares at the rate of $10.82 per share. Total worth of this trade was $7,036. Total number of shares owned as of Jun 09 were 1,353,089
- SEC Form 4 filing: May 12: Sold 1,200 shares at the rate of $11.09 per share. Total worth of this trade was $13,308. Total number of shares owned as of May 12 were 1,354,762
- SEC Form 4 filing: May 05: Sold 1,200 shares at the rate of $11.30 per share. Total worth of this trade was $13,560. Total number of shares owned as of May 05 were 1,355,962
Posted by
George Daniels
on Friday June 18 2021, 2:16 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
